Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
26 results
D2.63 - Airborne allergic contact dermatitis in a textile worker: role of formaldehyde and methylisothiazolinones
D2.64 - Occupational allergic contact dermatitis due to rubber additives: clinical features and occupational implications
D2.72 - Radiological heterogeneity and inflammatory phenotypes in allergic bronchopulmonary aspergillosis
D2.58 - Nickel Sensitization and Reversible Airway Dysfunction: Evidence from Pulmonary Function Response to Nickel Avoidance
D2.59 - Refining Quality of Life Assessment in CSU: Validation and Threshold Determination of the CU-Q2oL questionnaire
D2.61 - Allergic Contact Dermatitis Due to Disperse Textile Dyes: A 10-Year Review
D2.62 - Atypical Chronic Cheilitis as Manifestation of Atopic Dermatitis: A Diagnostic Dilemma
D2.65 - Allergic cheilitis related to vaginal lubricant: a case report
D2.66 - Allergic contact dermatitis to cobalt and concomitant sensitization to nickel and chromium
D2.67 - Clinical Profile of Allergic Contact Dermatitis in Workers and Factors Associated with Occupational Outcomes
D2.114 - Occupational asthma and rhinitis in a worker in the single-use food packaging industry: challenges of multi-agent exposure
D2.115 - Occupational asthma and rhinitis to isocyanates in industrial settings
D2.108 - Type 2 Inflammation Biomarkers in Patients with Chronic Rhinosinusitis with Nasal Polyps Under Treatment with Biologic Agents
D2.110 - Real-world evaluation of tezepelumab in patients with severe asthma and chronic rhinosinusitis in France: preliminary results from the ROSE retrospective study
D2.113 - Comparison of Non-Asthmatic Allergic Rhinitis Patients with Normal and Low FEF25–75 Levels
D2.120 - Missing the Red Flags? Identification of High-Risk Paediatric Asthma Admissions Following the 2024 BTS/NICE/SIGN Update
D2.121 - Seroprotection to influenza virus in vaccinated patients with bronchial asthma on biological treatment
D3.274 - Feasibility of Digestive Enzyme Supplementation for Cow’s Milk Allergy in Exclusively Breastfed Infants
D3.271 - Development of a multiplex assay to assess the risk of IgE cross-reactivity to new protein sources
D3.275 - In silico based assessment of intrinsic protein features for ranking clinical relevance of plant-based food allergens
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download